vorasidenib
servier
['indigo']
anticipation is building before, what will be a historic moment for neuro-oncology at #asco2023 - dr. ingo mellinghoff will be presenting indigo trial data at the plenary session 
Professor of Medicine and Neurology; Director-Neuro-Oncology Program; Director-Neuro-Oncology Fellowship Program, Mayo Clinic Arizona;